First nine months 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.


No votes yet
 
Related
ROVI tops the Sustainalytics sustainability ranking for the pharmaceutical subindustry worldwide Laboratorios Farmacéuticos ROVI...
2 min
01/08/2022
ROVI REPORTS OPERATING REVENUE GROWTH OF 31% AND NET PROFIT GROWTH OF 58%   Operating revenue increased by 31% to 380.4...
3 min
27/07/2022
Madrid, 19th July 2022 The European Investment Bank (EIB) is providing Laboratorios Farmacéuticos Rovi (ROVI) with a new EUR 50 million...
4 min
19/07/2022